iHuman (IH) EBITDA (2019 - 2025)

iHuman (IH) has 7 years of EBITDA data on file, last reported at $1.3 million in Q4 2025.

• EBITDA for Q4 2025 came in at $1.3 million, down 37.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.3 million (down 6.96% YoY), and the FY2025 annual result was $12.5 million, down 12.68% from the prior year.
• EBITDA eased to $1.3 million in Q4 2025 per IH's latest filing, from $2.3 million in the prior quarter.
• Over five years, EBITDA peaked at $8.3 million in Q1 2023 and troughed at -$6.8 million in Q3 2021.
• A 5-year average of $2.5 million and a median of $2.6 million in 2024 frame the typical range for EBITDA.
• The sharpest annual moves came in 2021 and 2022: EBITDA plunged 448.04% in 2021, then surged 731.95% in 2022.
• A 5-year view of EBITDA shows it stood at -$1.7 million in 2021, then soared by 442.07% to $5.7 million in 2022, then tumbled by 45.64% to $3.1 million in 2023, then slumped by 33.74% to $2.0 million in 2024, then plunged by 37.04% to $1.3 million in 2025.
• Business Quant data shows IH's EBITDA at $1.3 million in Q4 2025, $2.3 million in Q3 2025, and $2.7 million in Q2 2025.